Zoll enrolls first patient in groundbreaking sscore commercial registry at minneapolis heart institute at abbott northwestern hospital (minneapolis, mn)

Chelmsford, mass.--(business wire)--zoll®, an asahi kasei company that manufactures medical devices and related software solutions, announced today that the first patient has been enrolled in the supersaturated oxygen comprehensive observational registry (sscore). the prospective study is designed to provide further evidence of the efficacy of supersaturated oxygen (sso2) therapy to reduce heart failure and mortality in patients suffering from left anterior descending st-elevation myocardial in.
ABT Ratings Summary
ABT Quant Ranking